A Review of Investigational Treatments for Covid-19 - Zinc Supplementary

Dr. K. Deepa; Dr. Preethi Anand; Dr. S. Kothai

doi:10.46243/jst.2021.v6.i3.pp17-20

A Review of Investigational Treatments for Covid-19 - Zinc Supplementary

Authors

Dr. K. Deepa
Dr. Preethi Anand
Dr. S. Kothai

DOI:

https://doi.org/10.46243/jst.2021.v6.i3.pp17-20

Keywords:

: COVID-19, SARS-CoV-2, Immune system, Zinc supplement

Abstract

Zinc (Zn) is an investigational agent against Coronavirus disease 2019 (COVID-19) and has known protective and medicinal function for other infections. Due to the quick increase and vast number of pretentious individuals worldwide, cost-effective, globally available, and safe options with minimal side effects and simple application are extremely warranted. Zn deficiency is associated with lower survival among older patients with pneumonia and predisposes to other viral infections. Zn supplement has an efficacious against COVID-19 and to improve normal immune cell function, in particular in elderly patients. Zinc may decrease the activity of the angiotensin converting enzyme 2, the receptor for SARS-CoV-2. Zinc T-cell modulation may down regulate the cytokine storm associated with severe COVID-19. Therefore, it may be suggested that Zn supplementation may be of potential support for treatment of COVID-19

Downloads

Published

2021-05-20

How to Cite

Dr. K. Deepa, Dr. Preethi Anand, & Dr. S. Kothai. (2021). A Review of Investigational Treatments for Covid-19 - Zinc Supplementary. Journal of Science & Technology (JST), 6(3), 17–20. https://doi.org/10.46243/jst.2021.v6.i3.pp17-20